Leo Orr, MD
Basic profileLeo Orr is an Oncology physician affiliated with University of Southern California. OpenAlex indexes 10 publications with 274 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
73 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202521 payments$644
- Novartis Pharmaceuticals CorporationProgram year202514 payments$288
- PFIZER INC.Program year202510 payments$255
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
75.8%RANK Ligand Inhibitor75.8%Denosumab100%Part B, office-administered≥28 patientsMetabolism & gastrointestinal
6.7%Serotonin-3 Receptor Antagonist6%Ondansetron hydrochloride91%Ondansetron Hcl9%Part D + Part B≥12 patientsOsmotic Laxative0.4%Lactulose100%Part D<11 patients+ 1 more class in this area
Sensory organs
6.5%Corticosteroid6.5%Dexamethasone sodium phosphate100%Part B, office-administered≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Siamak Daneshmand, MD
University of Southern California
David Freyer, DO
University of Southern California
Andrew Moshfeghi, MD
University of Southern California
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”